Read the full stored bill text
A2188 TR
ASSEMBLY, No. 2188
STATE OF NEW JERSEY
222nd LEGISLATURE
�
PRE-FILED FOR INTRODUCTION IN THE 2026 SESSION
Sponsored by:
Assemblywoman SHANIQUE SPEIGHT
District 29 (Essex and Hudson)
Assemblywoman VERLINA REYNOLDS-JACKSON
District 15 (Hunterdon and Mercer)
Assemblywoman� DAWN FANTASIA
District 24 (Morris, Sussex and Warren)
Co-Sponsored by:
Assemblywomen Peterpaul, Donlon, Assemblymen Tully and
Karabinchak
SYNOPSIS
���� Establishes requirements to evaluate certain people
who are pregnant and who have given birth for preeclampsia.
CURRENT VERSION OF TEXT
���� As reported by the Assembly Community Development and
Women's Affairs Committee with technical review.
��
An Act
concerning preeclampsia
evaluations
and
supplementing Title 26 of the Revised Statutes.
����
Be It
Enacted
by the Senate and General Assembly of
the State of New Jersey:
���� 1.��� a.� Every birthing
center licensed in the State pursuant to P.L.1971, c.136 (C.26:2H-1 et seq.),
every federally qualified health center, and every licensed health care
practitioner providing prenatal
care to a pregnant person, or postpartum care to
a person
who seeks treatment within 12 weeks of giving birth, shall adopt and adhere to
policies requiring the person to be evaluated, as necessary, for hypertensive
disorders related to pregnancy, including, but not limited to, postpartum
preeclampsia and hypertension, if the person shows symptoms of the condition
and has not in the current or recent pregnancy previously been diagnosed with
the condition or after the onset of such symptoms.� Evaluation tools shall be
based on best practices and guidance, as determined by the American College of
Obstetricians and Gynecologists or another nationally-recognized body.
���� b.��� Every
birthing
center licensed in the State pursuant to P.L.1971, c.136 (C.26:2H-1 et seq.),
every federally qualified health center, and every licensed health care
practitioner providing prenatal care to a pregnant person, or postpartum care
to a person who seeks treatment within 12 weeks of giving birth, shall, in
accordance with nationally recognized evidence-based treatment practices:
���� (1)�� provide the person with
evidence-based information on hypertensive disorders related to pregnancy
preeclampsia, including, but not limited to, postpartum preeclampsia and
hypertension and potential warning signs and symptoms;
���� (2)�� inform the person of the
benefits of being evaluated for hypertensive disorders related to pregnancy
preeclampsia, including, but not limited to, postpartum preeclampsia and
hypertension, if the person shows symptoms of any such disorders, and that the
person should be evaluated for hypertensive disorders related to pregnancy
under the circumstances set forth in this section unless the person declines to
be evaluated; and
���� (3)�� upon receipt of the
results of any evaluation conducted pursuant to this section, discuss the
results with the person and, if the person has a positive evaluation for
preeclampsia, develop an evidence-based treatment plan to minimize the person�s
risk from preeclampsia.
���� 2.��� The Commissioner of
Health may adopt rules and regulations, in accordance with the �Administrative
Procedure Act,� P.L.1968, c.410 (C.52:14B-1 et seq.), as are necessary to
effectuate the purposes of this act, and the State Board of Medical Examiners,
and any other agency or board that regulates health care practitioners subject
to the requirements of section 1 of this act, shall promulgate rules and
regulations as are necessary to effectuate the purposes of this act.
���� 3.��� This act shall take
effect 180 days following enactment.